A rapid rescue treatment
Someone else will need to administer ZEGALOGUE® if you have very low blood sugar. It's important to be aware of the signs and symptoms of very low blood sugar, and review the Instructions for Use for complete administration instructions with the people close to you.
Autoinjector shown, also available as
a prefilled syringe. Not actual size.
A rapid rescue treatment
ZEGALOGUE® is a rescue treatment that helps people with diabetes (aged 6 and over) recover from very low blood sugar (severe hypoglycemia) when they need help
from others.
Actor portrayals;
before administration
A rapid rescue treatment
In clinical trials, median time to blood sugar recovery was 10 minutes in adults, adolescents, and children aged 6 years and older.
ZEGALOGUE® was studied in a clinical trial program of people with type 1 diabetes. Two trials were conducted in adults, and a third trial was conducted in children and adolescents aged 6 to 17 years. In all 3 trials, the results of participants who received ZEGALOGUE® were compared with the results of those who received a placebo following insulin-induced low blood sugar. The primary goal in all 3 trials was to measure the time to blood sugar recovery, defined as an increase in blood sugar of at least 20 mg/dL from the time of administration, without additional intervention.
Actor portrayals;
before administration
A rapid rescue treatment
In clinical trials, blood sugar levels recovered with a single dose.
ZEGALOGUE® was studied in a clinical trial program of people with type 1 diabetes. Two trials were conducted in adults, and a third trial was conducted in children and adolescents aged 6 to 17 years. In all 3 trials, the results of participants who received ZEGALOGUE® were compared with the results of those who received a placebo following insulin-induced low blood sugar. The primary goal in all 3 trials was to measure the time to blood sugar recovery, defined as an increase in blood sugar of at least 20 mg/dL from the time of administration, without additional intervention.
Actor portrayals;
before administration
A rapid rescue treatment
Someone else will need to administer ZEGALOGUE® if you have very low blood sugar. It's important to be aware of the signs and symptoms of very low blood sugar, and review the Instructions for Use for complete administration instructions with the people close to you.
Autoinjector shown, also available as
a prefilled syringe. Not actual size.
A rapid rescue treatment
ZEGALOGUE® is a rescue treatment that helps people with diabetes (aged 6 and over) recover from very low blood sugar (severe hypoglycemia) when they need help
from others.
Actor portrayals;
before administration
A rapid rescue treatment
In clinical trials, median time to blood sugar recovery was 10 minutes in adults, adolescents, and children aged 6 years and older.
ZEGALOGUE® was studied in a clinical trial program of people with type 1 diabetes. Two trials were conducted in adults, and a third trial was conducted in children and adolescents aged 6 to 17 years. In all 3 trials, the results of participants who received ZEGALOGUE® were compared with the results of those who received a placebo following insulin-induced low blood sugar. The primary goal in all 3 trials was to measure the time to blood sugar recovery, defined as an increase in blood sugar of at least 20 mg/dL from the time of administration, without additional intervention.
Actor portrayals;
before administration
A rapid rescue treatment
In clinical trials, blood sugar levels recovered with a single dose.
ZEGALOGUE® was studied in a clinical trial program of people with type 1 diabetes. Two trials were conducted in adults, and a third trial was conducted in children and adolescents aged 6 to 17 years. In all 3 trials, the results of participants who received ZEGALOGUE® were compared with the results of those who received a placebo following insulin-induced low blood sugar. The primary goal in all 3 trials was to measure the time to blood sugar recovery, defined as an increase in blood sugar of at least 20 mg/dL from the time of administration, without additional intervention.
Actor portrayals;
before administration
A rapid rescue treatment
Someone else will need to administer ZEGALOGUE® if you have very low blood sugar. It's important to be aware of the signs and symptoms of very low blood sugar, and review the Instructions for Use for complete administration instructions with the people close to you.
Autoinjector shown, also available as
a prefilled syringe. Not actual size.
If you have commercial insurance, such as insurance you receive through an employer, depending on your insurance coverage and out-of-pocket responsibility, you may pay $35 or $99 for each one-pack prescription for up to 48 months from date of Savings Offer activation.*
Call 1-833-992-3301 to get a Savings Offer.
Reaching very low blood sugar levels can be dangerous to those living with diabetes, and it's important to have an action plan ready. Make sure you are informed and well prepared to handle those situations, which includes having a rescue treatment available.
Find confidence in being prepared. ZEGALOGUE® was evaluated across 3 clinical trials to measure blood sugar recovery time.
ZEGALOGUE® (dasiglucagon) injection is a prescription medicine used to treat very low blood sugar (severe hypoglycemia) in people with diabetes aged 6 years and older. It is not known if ZEGALOGUE® is safe and effective in children under 6 years of age.
The most common side effects of ZEGALOGUE® include: in adults: nausea, vomiting, headache, diarrhea, and injection site pain; in children: nausea, vomiting, headache, and injection site pain. These are not all the possible side effects of ZEGALOGUE®.
Please see ZEGALOGUE® Full Prescribing Information, including Patient Information.
ZEGALOGUE® (dasiglucagon) injection is a prescription medicine used to treat very low blood sugar (severe hypoglycemia) in people with diabetes aged 6 years and older. It is not known if ZEGALOGUE® is safe and effective in children under 6 years of age.
ZEGALOGUE® (dasiglucagon) injection is a prescription medicine used to treat very low blood sugar (severe hypoglycemia) in people with diabetes aged 6 years and older. It is not known if ZEGALOGUE® is safe and effective in children under 6 years of age.
The most common side effects of ZEGALOGUE® include: in adults: nausea, vomiting, headache, diarrhea, and injection site pain; in children: nausea, vomiting, headache, and injection site pain. These are not all the possible side effects of ZEGALOGUE®.
Please see ZEGALOGUE® Full Prescribing Information, including Patient Information.
ZEGALOGUE® (dasiglucagon) injection is a prescription medicine used to treat very low blood sugar (severe hypoglycemia) in people with diabetes aged 6 years and older. It is not known if ZEGALOGUE® is safe and effective in children under 6 years of age.
ZEGALOGUE® is a registered trademark of Novo Nordisk A/S.
Novo Nordisk is a registered trademark of Novo Nordisk A/S.
All other trademarks, registered or unregistered, are the property of their respective owners.
© 2024 Novo Nordisk All rights reserved. US23ZGL00030 February 2024
Are you a health care professional?
The information in this section of the website is intended for US health care professionals only.
Are you ready to leave?
You are now leaving ZEGALOGUE.com
By clicking the “Continue” button below, you will be taken to a website that may contain links or references to other websites in which our privacy policy may not apply. We encourage you to read the privacy policy of every website you visit. By clicking the “No thanks” button below, you will be taken to the page you were on previously.